Buda Juice, Inc. BUDA
Company Overview
Buda Juice, Inc. engages in producing and distributing juice, lemonades, limeades, and wellness shots in the United States. The company offers clean-label beverages; citrus juices; and cold-pressed juices made from fruits and vegetables. The company serves wholesale clients. The company was incorporated in 2013 and is headquartered in Dallas, Texas.
Why Investors Should Care
Generates a return on equity of 19.3%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 78.6%.
Revenue has grown at a 11.8% CAGR over the past five years.
Maintains a net profit margin of 17.1%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $12.61M (+11.8% YoY); net profit $3.53M.
- Trailing 12 Months Year-on-year growth — revenue +26.4%, earnings -1.1%.
- 5-Year Trend Long-term compounding — revenue CAGR 11.8%, profit CAGR -1.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 11.84% |
| 1 Year: | 26.40% |
Compounded Profit Growth
| 5 Years: | -1.15% |
| 1 Year: | -1.15% |
Stock Price Performance
| 1 Year: | -6.29% |
| 6 Months: | -15.56% |
| 3 Months: | -10.59% |
| 1 Month: | -6.17% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- RSI (14)37.38 · Neutral
P/E of 40.00 is above the sector median of 18.56 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Healthy ROCE of 78.6%.
- Compounding revenue at 11.8% over 5 years.
- Generates positive free cash flow.
CONS
- Earnings shrank at -1.1% CAGR over 5 years.
- Trading 30.0% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | BUDA Buda Juice, Inc. | 7.60 | 40.00 | $95.51M | 0.00% | 78.65% | 19.30% | 11.84% | -1.15% |
| 2 | WMT Walmart Inc. SPXR3K | 107.14 | 38.82 | $850.02B | 0.93% | 16.83% | 22.31% | 3.82% | 3.24% |
| 3 | COST Costco Wholesale Corporation NDXSPXR3K | 910.18 | 45.88 | $403.65B | 0.65% | 25.96% | 29.15% | 8.16% | 11.45% |
| 4 | KO The Coca-Cola Company SPXR3K | 88.36 | 26.53 | $380.17B | 2.41% | 16.47% | 42.05% | 2.86% | 4.46% |
| 5 | PG The Procter & Gamble Company SPXR3K | 145.58 | 21.99 | $338.39B | 2.95% | 22.49% | 30.29% | 0.52% | 1.59% |
| 6 | PM Philip Morris International Inc. SPXR3K | 184.73 | 25.37 | $287.92B | 3.09% | 34.03% | -113.55% | -1.69% | 3.57% |
| 7 | PEP PepsiCo, Inc. NDXSPXR3K | 138.45 | 18.15 | $189.12B | 4.43% | 15.41% | 51.51% | 4.93% | 2.11% |
| 8 | BUD Anheuser-Busch InBev SA/NV | 79.73 | 17.18 | $139.30B | 1.69% | 8.49% | 11.39% | 0.88% | 4.63% |
| 9 | BTI British American Tobacco p.l.c. | 55.15 | 14.18 | $118.73B | 5.98% | 12.44% | 13.42% | -2.53% | 5.21% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue | 2.98M | 3.51M |
| Gross Profit | 1.34M | 1.39M |
| Operating Income | 803.00K | 593.00K |
| Net Income | 807.00K | 388.00K |
| Diluted EPS | - | 0.03 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Revenue | 11.27M | 12.61M |
| Gross Profit | 5.21M | 5.63M |
| Operating Income | 3.41M | 3.45M |
| Net Income | 3.57M | 3.53M |
| Diluted EPS | 0.20 | 0.20 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Total Assets | - | 3.73M | 4.97M |
| Total Equity | 401.00K | 3.16M | 3.74M |
| Total Liabilities | - | 575.00K | 1.23M |
| Current Liabilities | - | 575.00K | 585.00K |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Operating Cash Flow | 3.97M | 3.15M |
| Investing Cash Flow | -684.00K | -246.00K |
| Financing Cash Flow | -2.83M | -2.95M |
| Capital Expenditure | -684.00K | -246.00K |
| Free Cash Flow | 3.29M | 2.90M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Gross Margin % | 46.2% | 44.6% |
| Operating Margin % | 30.3% | 27.4% |
| Net Margin % | 31.7% | 28.0% |
| ROE % | 113.2% | 94.5% |
| ROCE % | 108.1% | 78.7% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Bard Associates Inc. | 2.33% | 293.06K | $2.33M |
| 2 | Vanguard Capital Management LLC | 0.30% | 37.27K | $296.68K |
| 3 | Geode Capital Management, LLC | 0.19% | 23.28K | $185.33K |
| 4 | Vanguard Fiduciary Trust Co | 0.13% | 16.40K | $130.56K |
| 5 | Blackrock Inc. | 0.10% | 12.03K | $95.73K |
| 6 | SOA Wealth Advisors, LLC | 0.03% | 3.33K | $26.51K |
| 7 | UBS Group AG | 0.01% | 704 | $5.60K |
| 8 | Osaic Holdings Inc. | 0.01% | 1.20K | $9.55K |
| 9 | Arax Advisory Partners | - | 200 | $1.59K |
| 10 | Tower Research Capital LLC (TRC) | - | 594 | $4.73K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BUDA
BUDA (BUDA) Stock Forecast and Price Target 2026 - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9sbl9HYzd5ME04WXN6RVdYQ3hlY3pmQVR5c21LeVdTbEFGWFBnX2xsTHV5YXY4TzhSTlkzc0lIVC1ZbGlLaGp6YWNVWURkNEZDV3ZMQVcyQ2NlMk45TnJuaEllakIwTEtOLUgxVWZR?oc=5" target="_blank">BUDA (BUDA) Stock F…
Buda Juice (BUDA) Stock Price Jumps As Margins Shrink And Valuation Stretches - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxOQ09DQ2pWUTYwWHYycTVmQllkSmQ1V0tFVjctT05GV3lZa01hZ1VWN1p5U1ZrWWl6SFlmTUlXZEFPY3Z2a2ktTHBoV2dOS3VqTFY0alp5SDRJMkpNMmVtdFVBd25NYjNDMTdwX3RnUWtfcFVQSTBNb3VJMlFDSGw4MWlOV2R0d0JtUVdEa3…
Does Buda Juice (BUDA) Have a Long Runway for Growth? - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxNSTZkb1dMdFc0MmhtVlQ4anJTeEUxUTNhTHZzdm9YUVpIRFZSbHFxR2QwRU9fNGcxOS1wQlBvaWZKZmFZaEd2SVVtMGVmQk5WZWF1TFBoWExZRXVybjNZXzdrRVB1MlZKZno4NDQtM05yc2pqdHVsNDdyb1J0bS1fNkk4R1Y2bkozYmtJSX…
Buda Juice Stock: The Optionality Isn't Mine (NYSE:BUDA) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxNMlNWdlpSYlhQWVVmZi1pVzQweUowenRiaGc3V1BMblR6QnJ4ZDdab0k3aTZVRGd2cEN4aTNkZlZyckZ3TDRySVNjQWdEQ19qWTMzRFB5bDJnVFRSNlFOakEwZG9pLWZaby1XUjl4S2ZZM24tcDJrOUhiOTVHUDNBU3FWZw?oc=5" targe…
Buda Juice (BUDA) Stock Price, News & Analysis - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTFBnMkJRaWNYLWJXR1lrT1dxel9RU2ZPY2EyM0VQcFBWQzRqYmJnMElmSW5nT2VMVHNiekxkWHV3LXZydjNVaEJWWlpzWWE4N0laY28w?oc=5" target="_blank">Buda Juice (BUDA) Stock Price, News & Analysis</a> …
Earnings call transcript: Buda Juice posts 26.4% revenue growth in Q2 2026 - Investing.com
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxOTWZfYUJYMzRsQnRWUV9YaHBVelkxYVNvV2k2Q0MyamVwUVBzd2FhWXBMc2xEUWIzWWdBOUVPOU9TbmxHemFSTjJha3FvN2pPYktrX1RueGpYdDBqUnVCY0I4MEwxQlB1SEtBWmw1Z0I1WGUwRWRhMWxsNnlLMU82cHlfRXFiRExJNHNpN2…
BUDA — Frequently Asked Questions
What is the current share price of Buda Juice, Inc. (BUDA)?
As of 2026-09-19 21:16 PDT, Buda Juice, Inc. (BUDA) trades at $7.60 on NYSE American. Its 52-week range is $7.16 to $10.86.
What is the market capitalisation of BUDA?
Buda Juice, Inc. (BUDA) has a market capitalisation of $95.51M on NYSE American.
What is the P/E ratio of BUDA?
BUDA trades at a trailing price-to-earnings (P/E) ratio of 40.00. The industry average P/E is 18.56. Its price-to-book (P/B) ratio is 4.64.
What is the return on equity (ROE) of BUDA?
BUDA has a return on equity (ROE) of 19.30%. Its return on capital employed (ROCE) is 78.65%.
Is BUDA a good stock to buy?
This page provides a data-driven analysis of Buda Juice, Inc. (BUDA), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.